current estimates of dysautonomia in long covid
on april 28, 2022 dysautonomia international issued a press release summarizing the results of the largest study of dysautonomia in long covid to date. the study comes from researchers at stanford university, stony brook university, and dysautonomia international.
long story short: an estimated 67% of people with long covid have autonomic nervous system dysfunction, also known as dysautonomia. in the united states, that comes to 38 million people out of a 330 million population who currently have moderate to severe long covid dysautonomia.
the study also concludes that "Moderate to severe autonomic dysfunction was seen in all PASC* groups in our study, independent of hospitalization status, suggesting that autonomic dysfunction is highly prevalent in the PASC population and not necessarily dependent on the severity of acute COVID illness."
*post-acute sequalae of SARS-CoV-2 (PASC), or long COVID
as in, you can have a very mild case of covid-19 and still develop significant autonomic nervous system dysfunction as a result.
to learn more about dysautonomia, how it works, the latest research, how it is treated, and how close we are to some cures: join me in registering for the dysautonomia international's 2022 virtual medical conference july 14-17, 2022. medical experts will be discussing many different types of autonomic dysfunction, their comorbidities, and what to do about this long covid dysautonomia crisis.
this year's theme is collaborating for cures.
register for the conference: dysautonomiainternational.org/dysconf2022
link to study: medrxiv.org/content/10.1101/2022.04.25.22274300v1
dysautonomia international: https://dysautonomiainternational.org/
press release (pdf): https://dysautonomiainternational.org/pdf/LongCOVID_Dysautonomia_PressRelease.pdf
donate to long covid research: longcovidresearchfund.org